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eipzig, Germany
Objectives This study investigated the impact of sheath size on the rate of radial artery occlusions
(RAO) (primary objective) and other access site complications (hemorrhage, pseudoaneurysm, arte-
riovenous ﬁstula) as secondary objectives after transradial coronary catheterization.
Background The number of vascular access complications in the published data ranges from
5% to 38% after transradial catheterization.
Methods Between November 2009 and August 2010, 455 patients 65.3  10.9 years of age (62.2%
male) with transradial access with 5-F (n  153) or 6-F (n  302) arterial sheaths were prospectively
recruited. Duplex sonography was obtained in each patient before discharge. Patients with symptomatic
RAO were treated with low-molecular-weight heparin (LMWH), and a follow-up was performed.
Results The incidence of access site complications was 14.4% with 5-F sheaths compared with
33.1% with 6-F sheaths (p  0.001). Radial artery occlusion occurred in 13.7% with 5-F sheaths com-
pared with 30.5% with 6-F sheaths (p  0.001). There was no difference between groups with
regard to hemorrhage, pseudoaneurysms, or arteriovenous ﬁstulas. Female sex, larger sheath size,
peripheral arterial occlusive disease, and younger age independently predicted RAO in multivariate
analysis. In total, 42.5% of patients with RAO were immediately symptomatic; another 7% became
symptomatic within a mean of 4 days. Of patients with RAO, 59% were treated with LMWH. The
recanalization rates were signiﬁcantly higher in patients receiving LMWH compared with conven-
tional therapy (55.6% vs. 13.5%, p  0.001) after a mean of 14 days.
Conclusions The incidence of RAO by vascular ultrasound was higher than expected from previous
data, especially in patients who underwent the procedure with larger sheaths. (J Am Coll Cardiol
Intv 2012;5:36–43) © 2012 by the American College of Cardiology Foundation
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37Since the first successful diagnostic transradial coronary
catheterization by Campeau in 1989 (1) and the first
transradial percutaneous coronary intervention (PCI) by
Kiemeneij in 1993 (2), the radial artery has been increas-
ingly used as an access site for coronary procedures, because
of lower rate of access site complications, shorter hospital
stay, improved patient comfort, and safe hemostasis (3,4)
compared with transfemoral access (5–7). Nonetheless,
radial access still accounts for only 10% of coronary cath-
eterizations worldwide and for 2% of coronary procedures
in the United States (8). Bleeding at the vascular access site
is an important predictor for post-interventional morbidity
and mortality as demonstrated in several studies (7,9–15).
See page 44
The recently published multicenter RIVAL (radial versus
femoral access for coronary intervention) trial (15) was
conducted to compare radial with femoral access in the
setting of acute coronary syndromes. The radial access was
shown to reduce major vascular complications compared
with the femoral access. Another interesting finding was the
mortality reduction in favor of transradial access in patients
with ST-segment elevation myocardial infarction.
The rate of post-procedural radial artery occlusion (RAO)
and the increased radiation exposure (16,17) remain the pri-
mary concern of transradial access. Although radiation expo-
sure mainly depends on operator training and experience with
transradial coronary angiography (18), a number of factors
might affect RAO rate. In the published data, RAO rates are
surprisingly different, ranging from 5% to 38% (19–22). The
large variance might be related to the fact that radial artery
patency after catheterization was assessed by clinical forearm
inspection and pulse palpation rather than vascular ultrasound
in the vast majority of studies (23). To quantify the true rate
and to elucidate risk factors for access site complications, we
conducted the present prospective registry with high-
resolution vascular ultrasound after transradial diagnostic
angiography and PCI with 5-F and 6-F vascular sheaths.
Methods
Patient cohort. Between November 2009 and August 2010,
455 consecutive patients undergoing transradial cardiac
catheterization at our high-volume tertiary care center were
enrolled in this prospective registry. Informed consent for
transradial coronary catheterization, including the follow-up
Doppler examination, was obtained in all patients.
Vascular risk factors (hypertension, hyperlipoproteinemia,
diabetes, and smoking) were assessed with standard defini-
tions. The presence of coronary artery disease (CAD),
peripheral arterial occlusive disease (PAOD), and cerebro-
vascular disease was recorded in all patients. An Allen test
was not routinely performed, because there is no clear Mconsensus with regard to the optimum cutoff time for a
positive Allens test. As reported by Jarvis et al. (24), the use
of Allen test for assessment of the ulnar collateral blood
supply of the hands is unreliable and does not satisfactorily
perform as a discriminatory test. Currently, criteria for an
abnormal Allen test are clinically not well defined, and
performing an Allen test is still not considered “standard
care” (25,26).
Transradial coronary catheterization. Six-French sheaths
RADIFOCUS Introducer II, Terumo, Europe N.V, Leu-
en, Belgium) (outer diameter 2.10 mm, 7-cm length) were
sed in 302 patients, and 5-F sheaths (Engage TR Intro-
ucer, SJM TM, St. Jude Medical, Inc., St. Paul, Minne-
ota) (outer diameter 1.92 mm, 7-cm length) were em-
loyed in 153 patients. In the absence of large prospective trials
e liberally used 6-F sheaths in patients with high risk for
AD. In particular, in patients presenting with acute coronary
yndromes, a 6-F sheath was used more frequently because of
he anticipated higher likelihood of PCI.
All sheaths were hydrophilic-
oated. After local anesthesia
ith xylocaine 2% the right ra-
ial artery was punctured in 442
atients (97.1%), whereas in 13
atients (2.9%) the arterial ac-
ess site was the left radial artery.
nfractionated heparin of 2,500
U was administered for a diag-
ostic angiography, and in total
00 IU/kg body weight was
iven for PCI. An intra-arterial
olus of 0.2 mg nitroglycerin
as routinely given to prevent
rterial spasm. Verapamil was
nly administered in the occur-
ence of spasm of the radial artery. After completion of the
ardiac catheterization procedure, sheaths were removed
mmediately and a compression device (RadiStop, St. Jude
edical Inc., or Terumo TR BAND, Terumo) was applied
ccording to the instructions of the manufacturer to achieve
emostasis. The TR BAND was applied with occlusive
ompression, slow removal of air until bleeding occurred,
nd then re-insufflation of 1 to 2 ml of air. RadiStop
ompression devices were applied with palpation of the
ulse of the radial artery distal to the compression site, and
n case of an absent pulse, the device was loosened until the
ulse was palpable again or bleeding occurred.
Vascular ultrasound. Color Doppler ultrasound studies were
erformed by experienced sonographers in all 455 patients
ithin 1.0  1.3 days after the procedure to examine the
adial, ulnar, and brachial arteries of the access forearm with
Vivid 7 ultrasonography system (General Electric Medical
ystems, Andover, Massachusetts) featuring a 9- to 12-
Abbreviations
and Acronyms
CAD  coronary artery
disease
CI  confidence interval
LMWH 
low-molecular-weight-heparin
OR  odds ratio
PAOD  peripheral arterial
occlusive disease
PCI  percutaneous
coronary intervention
RAO  radial artery
occlusionHz multifrequency vascular probe.
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38Endpoints and deﬁnitions. The primary objective of the
tudy was the incidence of post-procedural RAO as con-
rmed by absence of antegrade flow in vascular high-
esolution ultrasound. Secondary objectives were other local
ccess site complications (bleeding events, pseudoaneurysm,
nd arteriovenous fistula), respectively. Bleeding events were
efined according to the Global Use of Strategies to Open
ccluded Arteries bleeding definitions (mild, moderate,
nd severe bleeding events) (14).
Follow-up. Symptomatic patients with RAO were treated
with low-molecular-weight heparin (LMWH) in body
weight-adjusted dose for 7 to 14 days. Asymptomatic
patients did not receive a specific therapy. In patients with
RAO, a follow-up was conducted after 7 to 14 days after the
transradial catheterization (clinical examination and vascular
ultrasound examination).
Statistical analysis. All data were prospectively collected and
ntered into the registry. Dichotomous variables are re-
orted as numbers and proportions. Continuous parameters
re presented as mean  SD. The 2 groups (5-F vs. 6-F)
ere compared by t tests for continuous variables. Nonpara-
metric variables were compared by Fisher exact tests, and
ordered proportions were compared by Armitage’s test for
trend. Potential risk factors for post-procedural RAO were
investigated first by univariate logistic regression. A multi-
variate logistic regression model with all significant variables
was established to estimate odds ratios (ORs) inclusive 95%
confidence bounds. All tests were performed as 2-sided at
significance level   5%.
Two separate analyses were performed to confirm that
baseline group differences (e.g., frequency of PCI) do not
confound our findings: first, we matched 2  153 patients
by 1:1 propensity matching before analysis. Propensity
scores were calculated by logistic regression model with
variables like age and body mass index significantly associ-
ated with 5-F and 6-F sheaths.
Statistical analyses were performed with SPSS (version
19.0, SPSS. Inc., Chicago, Illinois).
Results
Patient characteristics. A total of 455 consecutive patients
with a clinical indication for coronary catheterization who
successfully underwent the transradial coronary procedure
were included in the registry (Fig. 1).
In 302 patients (66.4%), a 6-F arterial sheath was used,
whereas in 153 patients (33.6%), the procedure was per-
formed with a 5-F arterial sheath. Baseline patient charac-
teristics are displayed in Table 1. Both groups did not differ
with regard to age, sex, cardiovascular risk factors, and oral
medication. Patients with CAD, especially triple vessel
disease, are over-represented in the 6-F sheaths group.
Procedural data. Procedural data are illustrated in Table 2.
n total, 389 patients (85.5%) underwent diagnostic coro- wary angiography, and in 66 patients (14.5%) a PCI was
erformed. The rate of PCI differed significantly between
he 2 groups (1.2% with 5-F sheaths vs. 21.2% with 6-F
heaths). The amount of contrast media was significantly
igher in the 6-F group (55 ml vs. 87 ml, p  0.001), and
eft ventriculographies were performed significantly more
ften in the 6-F group (38 vs. 114, p  0.006). There was,
owever, no significant difference in fluoroscopic time between
he 2 groups.
Vascular complication rates. Vascular access site complica-
tions are displayed in Tables 3 and 4.
The primary objective (RAO) occurred in 92 patients of the
6-F group and in 21 patients of the 5-F group (30.5% vs.
13.7%, p  0.001). In 22 patients (19.5%) with ultrasono-
graphic signs of RAO, the radial artery pulse was still palpable.
The secondary objective of the overall incidence of local
access site complications was 33.1% (n 100) in the 6-F
group versus 14.4% (n  22) in the 5-F group (p  0.001).
hree patients developed a pseudoaneurysm in the 6-F
roup (1.0%), whereas none was observed in the 5-F group
pNS). Two of these patients were treated successfully with
ltrasound-guided compression; however, 1 patient required a
urgical repair. Arteriovenous fistulas were detected in 3 pa-
ients (1.0%) of the 6-F group and in 1 patient (0.7%) of the
-F group (p NS) with no need for further specific therapy.
There were no moderate or severe access site bleedings
according to Global Use of Strategies to Open Occluded
Arteries definitions requiring blood transfusions or surgical
repair. Hematomas with a maximal size of 5 cm at the right
forearm were noted in 6 patients (2.0%) of the 6-F group
and in none of the 5-F group.
Predictors of RAO. The univariate analysis of predictors of
ost-procedural RAO is presented in Table 5. With 6-F
heaths, the presence of PAOD, younger age, and female
ex were strong predictors of post-procedural RAO. There
Figure 1. Study Flow Chart
A total of 455 patients were enrolled in the registry, of whom 389 patients
underwent diagnostic coronary catheterization with 5-F and 6-F sheaths. A
percutaneous coronary intervention was performed in 66 patients.as a strong trend toward a higher occurrence of RAO in
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39patients with known cerebrovascular disease in univariate
analysis.
In multivariate regression analysis, the use of 6-F
sheaths (OR: 2.68, 95% confidence interval [CI]: 1.56 to
4.59, p  0.001), female sex (OR: 2.36, 95% CI: 1.50 to
3.73, p  0.001), age (OR: per-year 0.96, 95% CI: 0.94
to 0.98, p  0.001), and the presence of PAOD (OR:
2.04, 95% CI: 1.02 to 4.22, p  0.04) were significantly
associated with post-procedural RAO in all patients.
Independent predictors for post-procedural RAO are
displayed in Figure 2.
Table 1. Baseline Patient Characteristics
5-F Sheath
(n  153)
6-F Sheath
(n  302) p Value
Age (yrs) 65.1 10.8 64.9 11.0 0.27
Male 97 (63.4%) 186 (61.6%) 0.76
Body mass index (kg/m2) 30.8 5.8 29.2 5.8 0.005
Hypertension 145 (95.4%) 290 (96.0%) 0.81
Diabetes mellitus 53 (34.9%) 101 (33.4%) 0.83
Dyslipidemia 100 (65.8%) 214 (70.9%) 0.28
Current smoking 22 (14.5%) 52 (17.2%) 0.50
History of smoking 31 (20.4%) 78 (25.8%) 0.24
Coronary artery disease 61 (39.9%) 177 (58.6%) 0.001
1-vessel disease 30 (19.6%) 76 (25.2%)
2-vessel disease 21 (13.7%) 50 (16.6%)
3-vessel disease 10 (6.5%) 51 (16.9%) 0.03
Acute coronary syndrome 6 (3.9%) 26 (8.6%) 0.08
Cerebrovascular disease 14 (9.2%) 26 (8.6%) 0.86
Peripheral arterial occlusive disease 10 (6.6%) 35 (11.6%) 0.10
Aspirin 93 (60.8%) 183 (60.6%) 1.00
Statins 81 (52.9%) 167 (55.7%) 0.62
Beta-blockers 99 (64.7%) 213 (71.0%) 0.20
ACE inhibitors 88 (57.5%) 169 (56.3%) 0.84
Angiotensin II receptor blockers 37 (24.2%) 83 (27.7%) 0.50
Calcium-channel blocker 40 (26.1%) 70 (23.3%) 0.56
LV ejection fraction (%) 57 10 56 11 0.58
Serum creatinine (mg/dl) 1.0 0.3 1.0 0.6 0.28
Platelets (103/l) 221 64 230 78 0.20
Hemoglobin (mg/dl) 13.8 1.4 13.7 1.7 0.46
Values are mean SD or n (%).
ACE angiotensin-converting enzyme; LV left ventricular.
Table 2. Procedural Data
5-F Sheath
(n  153)
6-F Sheath
(n  302) p Value
Percutaneous coronary intervention 2 (1.2%) 64 (21.2%) 0.001
Fluoroscopy duration (min) 3.6 3.3 4.1 4.1 0.19
Amount of contrast media (ml) 55 26 87 56 0.001
Left ventriculography 38 (24.8%) 114 (37.7%) 0.006
Right radial artery 151 (98.7%) 291 (96.4%) 0.24Values are mean SD or n (%).Subgroup analyses were performed, including 389 pa-
tients who underwent diagnostic angiography only (151
patients with 5-F, 238 patients with 6-F). The univariate
analysis of predictors of RAO in patients undergoing
diagnostic catheterization only is presented in Table 6.
With 6-F sheaths, the presence of PAOD, younger age, and
female sex were again strong predictors of post-procedural
RAO. Cerebrovascular disease was not associated with
a higher occurrence of RAO in patients with diagnostic
catheterization only (Tables 4 and 6).
In multivariate regression analysis all of our results
remained unchanged in patients who underwent diagnostic
catheterization only (Table 7).
PCI did not increase vascular access site complications in
the present registry.
In propensity score analysis of 2  153 patients (5-F and
6-F), again, all main results remained unchanged. Only the
presence of PAOD did not show a significant association
with the occurrence of RAO in these 306 patients.
Body mass index was not associated with a higher
occurrence of RAO (p  0.335).
Clinical course of patients with RAO. Of all patients with
AO, 42.5% (n  48) were symptomatic within 24 h after
he transradial coronary procedure. Another 8 patients
7.1%) became symptomatic within a mean of 4.1  2.1
ays (2 to 8 days) after the coronary catheterization, when
esuming physical activity at home. The most frequent
ymptoms were a painful forearm and thenar. Other symp-
oms were a loss of handgrip force and paresthesia. How-
Table 3. Vascular Access Site Complications
5-F Sheath
(n  152)
6-F Sheath
(n  303) p Value
Total number of access site complications 22 (14.5%) 104 (34.3%) 0.001
Radial artery occlusion 21 (13.7%) 92 (30.5%) 0.001
Pseudoaneurysm 0 (0%) 3 (1.0%) 0.56
Arteriovenous ﬁstula 1 (0.7%) 3 (1.0%) 1.00
Moderate/severe bleeding 0 (0%) 0 (0%) —
Mild bleeding 0 (0%) 6 (2.0%) 0.19
Values are n (%).
Table 4. Vascular Access Site Complications in Patients With
Diagnostic Catheterization Only (N  389)
5-F Sheath
(n  151)
6-F Sheath
(n  238) p Value
Total number of access site complications 22 (14.6%) 82 (34.5%) 0.001
Radial artery occlusion 21 (13.9%) 76 (31.9%) 0.001
Pseudoaneurysm 0 (0%) 2 (0.8%) 0.524
Arteriovenous ﬁstula 1 (0.7%) 3 (1.3%) 1.000
Moderate/severe bleeding 0 (0%) 0 (0%) —
Mild bleeding 0 (0%) 5 (2.1%) 0.161Values are n (%).
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40ever, critical limb ischemia did not occur in any patient. Of
the 113 patients with RAO, 22 patients were lost to follow
up. In 91 patients the first follow-up ultrasound examina-
tion was performed after a mean time interval of 9.3  5
days (range 2 to 37 days). Fifty-four symptomatic patients
were treated with LMWH in body weight-adjusted dose
(n  17) or in half-therapeutic dose in case of additional
dual antiplatelet therapy (n 37) over a mean time period of 6
7 days. Asymptomatic patients (n  37) were not treated
with LMWH. At time of first follow-up, the recanalization
rate of the radial artery was 31.5% (17 of 54) after treatment
with LMWH, compared with 5.4% (2 of 37) in patients
without an anticoagulatory therapy (p  0.003).
In patients with persistent RAO at first follow-up, a second
follow-up ultrasound study was conducted after a mean time
interval of 14 days after catheterization. At this time, the final
recanalization rate was 55.6% (30 of 54) in patients after
treatment with LMWH compared with 13.5% (5 of 37) in
patients without anticoagulation (p  0.001).
Figure 2. Odds Ratios for Potential Risk Factors for RAO in a Multivariate
In a multivariate model, the use of 6-F sheaths, female sex, younger age, and
Table 5. Univariate Association of Different Risk Factors With
Radial Artery Occlusion
p Value Odds Ratio
95% CI for
Lower
Odds Ratio
Upper
Female 0.001 2.110 1.370 3.247
Age* 0.005 0.973 0.954 0.992
6-F sheath 0.001 2.754 1.635 4.639
Peripheral arterial disease 0.037 1.986 1.042 3.783
Cerebrovascular disease 0.056 1.941 0.984 3.827
*Age increase of 1 year is associatedwith a little lower risk. However, this results in anodds ratio of
1.67 for a 10-years-younger patient.
CI confidence interval.with the occurrence of post-procedural radial artery occlusion (RAO).Discussion
The present large prospective registry demonstrates that
clinical assessment alone might miss clinically relevant RAO
and might therefore underestimate the true risk of RAO. In
addition, the present registry is, to the best of our knowl-
edge, the first to compare radial access site complications
between 5-F and 6-F sheaths. It confirms that 5-F sheaths
reduce the rate of RAO by as much as 55%—a finding with
significant implications for the routine use of transradial
coronary catheterization.
Routine radial artery ultrasound and the true rate of RAO. The
ate of vascular access site complications after transradial
oronary catheterization as monitored by vascular high-
esolution ultrasound examination was significantly higher
n the present registry than expected from previous studies
27–30). This finding implies that routine clinical radial
ulse checks might be inaccurate and insensitive in detect-
l
esence of peripheral arterial occlusive disease were signiﬁcantly associated
Table 6. Univariate Association of Different Risk Factors With
Radial Artery Occlusion in Patients With Diagnostic Catheterization Only
(N  389)
p Value Odds Ratio
95% CI for
Lower
Odds Ratio
Upper
Female 0.001 2.348 1.471 3.748
Age* 0.005 0.970 0.949 0.990
6-F sheath 0.001 2.904 1.700 4.961
Peripheral arterial disease 0.018 2.424 1.165 5.043
Cerebrovascular disease 0.247 1.570 0.732 3.368
*Age increase of 1 year is associated with only a small relative decrease in risk of RAO. However,
this difference results in an odds ratio of 1.67 for a 10-years-younger patient.
CI confidence interval.Mode
the pr
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41ing all RAO. As demonstrated by Bertrand et al. (31), the
incidence of RAO before hospital discharge is not assessed
in more than 50% of coronary procedures.
Interestingly, in the present study 22 patients showed
RAO in ultrasound while the radial pulse was still palpable.
This finding might be explained by the collateral circulation
from the palmar arches (19,32). In the study by Kerawala
et al. (32), the comparative blood pressure from the
opposite artery ranged from 58 to 85 mm Hg (mean 70.4
mm Hg). This again underlines the necessity of perform-
ing vascular ultrasound examinations in each patient
before discharge even if clinical assessment does not show
abnormalities.
In addition, the unreliability of clinical pulse control
might partly explain the large variation in the observed
incidence of RAO reported in the published data (20).
Effect of sheath size on the RAO rate. In the present
prospective registry the use of 6-F sheaths was indepen-
dently associated with an increased rate of post-procedural
RAO. As reported by Bertrand et al. (31), 5-F sheaths
remain less frequently used, whereas 6-F is the standard
sheath size in general practice. Although it might be
obvious that larger sheath diameters lead to increased
vascular trauma, the exact pathomechanism explaining this
finding remains incompletely understood. There is an in-
fluence of the inner diameter of the radial artery and the
outer diameter of the sheath on the rate of RAO (33).
Because we did not measure pre-procedural radial artery
diameter, we are unable to comment on the role of artery
diameter-to-sheath diameter mismatch as a reason of RAO.
Acute injuries of the radial artery after transradial coronary
intervention might also be assessed by optical coherence
tomography (34). The stretching effect of the sheath and the
passage of the sheath as well as spasms of the radial artery
might cause intimal flaps. Consequently, the mechanisms of
RAO in relation to sheath size should be further studied in
imaging studies with optical coherence tomography (arterial
dissection vs. thrombotic occlusion).
Other patient-related risk factors for RAO. Transradial PCI
did not increase the incidence of vascular access site com-
Table 7. Odds Ratios for Potential Risk Factors for
Radial Artery Occlusion in a Multivariate Model in Patients With
Diagnostic Catheterization Only
p Value Odds Ratio
95% CI for
Lower
Odds Ratio
Upper
6-F sheath 0.001 2.742 1.574 4.776
Age (10 yrs) 0.001 0.663 0.523 0.842
Female 0.001 2.591 1.575 4.264
Peripheral arterial disease 0.010 2.936 1.300 6.632
Cerebrovascular disease 0.336 1.524 0.646 3.598
CI confidence interval.plications compared with diagnostic angiographies. How-ever, the number of interventional patients in the current
registry might be too limited to draw definitive conclusions,
and this will require larger sample sizes.
Younger patients and women are at a higher risk for
RAO. These findings might be related to the smaller
average radial artery diameter in women and the complex
sympathetic autonomic innervations of the radial artery,
which might increase the risk of vascular spasms. The exact
mechanisms of post-procedural RAO remain unknown.
Deftereos et al. (35) reported a significant univariate asso-
ciation between flow-mediated dilation of the radial artery
and the occurrence of vascular spasm. In their study, female
sex tended to be more prone to radial artery spasm.
Moreover, our study demonstrates that patients with
known PAOD are at significantly higher risk of RAO. One
potential explanation is the relationship between atheroscle-
rosis and structural vascular changes (luminal narrowing,
intimal hyperplasia) (36).
Procedure-related risk factors. The relatively high rate of
RAO in the current study needs to be interpreted in the
context of the unselected patients from routine coronary
procedures. In contrast to a recently published study (37)
reporting an incidence of RAO after transradial cardiac
catheterization of only 10.5%, our registry represents a real
world scenario with a pool of interventionalists having
different degrees of experience with the transradial ap-
proach. The study by Zankl et al. (37) differs with regard to
the sheath sizes used (4-F, 5-F, 6-F) and the exclusive
selection of senior interventionalists (10,000 interven-
tions). Furthermore, the study was not designed to primarily
investigate the potential relation between sheath size and
RAO.
The optimal anticoagulatory therapy is regarded to play
an important role for prevention of RAO, but data are still
lacking about the optimal heparin dose. The influence of
unfractionated heparin or LMWH on the incidence of
RAO remains unclear with aspirin and clopidogrel pre-
treatment. A randomized study comparing a low dose
(2,000 IU) versus a standard dose of unfractionated heparin
(5,000 IU) in transradial diagnostic angiography did not
show a difference in the rate of RAO between the 2 groups.
Low-dose unfractionated heparin was reported to be safe
and not inferior to standard dose (38). A study by Spaulding
et al. (39) showed a rate of RAO of 24% in patients who
received 2,000 to 3,000 IU of unfractionated heparin com-
pared with 4.3% in patients who received 5,000 IU. As
reported by Bertrand et al. (31), most interventional cardi-
ologists use unfractionated heparin in a dose between 2,000
and 5,000 IU, whereas approximately 5% do not use heparin
for diagnostic coronary angiography. In the present study,
all patients with diagnostic angiography received 2,500 IU
of unfractionated heparin and in total 100 IU/kg body
weight when PCI was performed, resulting in a rate of
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42RAO of 13.7% with 5-F sheaths compared with 30.5% with
6-F sheaths.
Another important factor is the concept of achieving
radial artery hemostasis. The patent hemostasis has been
found to be highly effective in reducing RAO without
compromising hemostatic efficacy (19). The optimal com-
pression management is to aim just enough pressure to
avoid bleeding while maintaining antegrade flow of the
radial artery (40).
Clinical relevance of RAO. RAO might not be as harmless as
reviously thought (41). In the present registry 42.5% of
atients with RAO became symptomatic immediately, and
n additional 7% became symptomatic within a mean of 4
ays after the catheterization. This finding could be con-
rmed by Zankl et al. (37), reporting a percentage of 58.8%
f patients with RAO showing symptoms at the access site.
herefore, it is of important clinical relevance to detect all
ascular access site complications before discharge to be able
o initiate an appropriate treatment. This is also increasingly
mportant, because of the potential future medical relevance
f an open radial artery for repeat cardiac catheterizations,
emodialysis shunts, invasive hemodynamic monitoring, or
rterial bypass grafting.
Study limitations. Some limitations of the current study
eed to be addressed. First, because the study design is a
rospective registry and not a randomized study, a selection
ias cannot be ruled out. Second, we did not perform a
re-procedural vascular ultrasound of the access site with
easurement of the diameter of the radial artery. The third
imitation is due to the lack of performance of a pre-
rocedural Allen test routinely. The fourth limitation results
rom the nonstandardized follow-up intervals when RAO
as diagnosed (7 to 14 days). This was, however, not the
rimary endpoint of the present study. In consequence, this
resent study reflects a real world clinical setting of unse-
ected consecutive patients and experienced yet unselected
nterventional cardiologists. Finally, our study represents a
ingle-center experience with a limited number of patients,
espite being 1 of the largest prospective vascular ultrasound
egistries in radial catheterization to date.
onclusions
Radial access for catheterization did not show severe bleed-
ing events in our registry, but the rate of RAO by ultrasound
examination was higher than expected and reported previ-
ously. The use of 5-F sheaths for transradial access signif-
icantly decreased the rate of RAO by 55%, compared with
6-F sheaths.
The true rate of symptomatic RAO might be underesti-
mated at discharge, because 7% of patients have shown a
late onset of symptoms when resuming physical activity at
home. To optimize the post-procedural management of
patients with transradial coronary procedures, vascular ul-trasound of the access site before discharge might be a
valuable, objective, and noninvasive tool.
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